Skip to content
Data Deal Guide.Real Info. Trust. Independent.
All providers
Company-data partnership Provider website

Gradient Health

Sources reviewed 2026-10-17

Healthcare and payments data require additional regulatory and contractual review

The 20% figure is the provider's own illustrative “typical” rate, not a guaranteed offer or an industry benchmark, and is not used as a valuation-model input.

Healthcare data requires additional regulatory and contractual review before any licensing discussion.

What the provider says it does

Gradient Health says data partners contribute existing medical data; it handles transfer, de-identification, curation and review, then distributes the data for approved AI-development projects and shares project revenue with the partner. Its data-partner page illustrates a “20% (typical revenue share for data partners)”, allocated by the partner's share of studies in a deal, and says future use generates additional revenue. Its FAQ says terms depend on data type, scale and usability. These are Gradient Health's own statements and have not been independently verified.

Business model
Company-data partnershipMedical-data partnership: partners supply existing data; Gradient Health says it de-identifies, curates and licenses it to AI developer customers and shares revenue.
Seller intake
Public data-partner inquiry at https://gradienthealth.io/data-partner
Contracting party
Not publicly stated
Data focus
Medical and clinical data
Data types considered
Medical imaging / radiologyElectronic health recordsPathology reportsClinical recordsImaging metadataLongitudinal patient records
Intended uses
Training
Geography
Buyer-facing material describes data sourced “from around the globe”; seller country eligibility is not publicly stated
Stated handling & privacy
  • Gradient Health says it de-identifies and curates partner data before distribution; the method and residual re-identification risk must be confirmed.
  • Healthcare data is heavily regulated; the seller must confirm authority to share, patient privacy obligations and any required agreements before engaging.
Retention, deletion, resale
Not publicly stated
Payment / licensing model
Provider's data-partner page illustrates a typical 20% revenue share for data partners, allocated by share of studies in a deal, with additional revenue from future use. Its FAQ says terms depend on data type, scale and usability; the illustration is not a guaranteed offer.
Exclusivity
Not publicly stated
Referral program
Not publicly confirmed

Sources

Suggest an update to this profile